Henan Lingrui Pharmaceutical Co Ltd (600285) — Net Asset Quality Index

Latest as of March 2026: 61.8%

Henan Lingrui Pharmaceutical Co Ltd (600285) has a Net Asset Quality Index of 61.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.97 Billion minus total liabilities of CN¥2.28 Billion yields net assets of CN¥3.69 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 600285 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Quality Index

61.8%
Equity / Total Assets

Net Assets

CN¥3.69 Billion
CNY

Total Assets

CN¥5.97 Billion
CNY

Total Liabilities

CN¥2.28 Billion
CNY

Henan Lingrui Pharmaceutical Co Ltd Net Asset Quality Index Over Time (1997–2025)

This chart shows how Henan Lingrui Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 29 annual periods from 1997 to 2025. As of March 2026, the index stands at 61.8%, representing net assets of CN¥3.69 Billion against total assets of CN¥5.97 Billion CNY. See Henan Lingrui Pharmaceutical Co Ltd (600285) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Annual Net Asset Quality Index for Henan Lingrui Pharmaceutical Co Ltd (1997–2025)

The table below presents the year-by-year Net Asset Quality Index for Henan Lingrui Pharmaceutical Co Ltd from 1997 to 2025, covering 29 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 600285 stock market capitalisation.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2025 61.0% CN¥3.44 Billion CN¥5.64 Billion CN¥2.20 Billion ▼ -0.4 pp
2024 61.4% CN¥3.08 Billion CN¥5.02 Billion CN¥1.94 Billion ▲ +2.7 pp
2023 58.6% CN¥2.80 Billion CN¥4.77 Billion CN¥1.97 Billion ▼ -0.2 pp
2022 58.9% CN¥2.56 Billion CN¥4.34 Billion CN¥1.79 Billion ▼ -1.4 pp
2021 60.3% CN¥2.29 Billion CN¥3.79 Billion CN¥1.51 Billion ▼ -6.9 pp
2020 67.2% CN¥2.32 Billion CN¥3.46 Billion CN¥1.14 Billion ▲ +0.2 pp
2019 67.0% CN¥2.22 Billion CN¥3.32 Billion CN¥1.10 Billion ▼ -0.4 pp
2018 67.3% CN¥2.09 Billion CN¥3.11 Billion CN¥1.02 Billion ▲ +0.7 pp
2017 66.6% CN¥2.20 Billion CN¥3.31 Billion CN¥1.10 Billion ▼ -4.2 pp
2016 70.8% CN¥2.11 Billion CN¥2.98 Billion CN¥869.35 Million ▲ +7.2 pp
2015 63.7% CN¥1.72 Billion CN¥2.71 Billion CN¥984.58 Million ▲ +0.6 pp
2014 63.1% CN¥1.56 Billion CN¥2.47 Billion CN¥913.70 Million ▲ +3.3 pp
2013 59.8% CN¥984.89 Million CN¥1.65 Billion CN¥663.24 Million ▲ +5.9 pp
2012 53.8% CN¥696.97 Million CN¥1.29 Billion CN¥597.36 Million ▼ -2.8 pp
2011 56.6% CN¥684.01 Million CN¥1.21 Billion CN¥524.02 Million ▼ -2.6 pp
2010 59.2% CN¥709.69 Million CN¥1.20 Billion CN¥489.25 Million ▼ -3.8 pp
2009 63.0% CN¥645.69 Million CN¥1.02 Billion CN¥378.52 Million ▲ +6.3 pp
2008 56.8% CN¥549.72 Million CN¥968.27 Million CN¥418.55 Million ▼ -4.7 pp
2007 61.5% CN¥579.24 Million CN¥942.55 Million CN¥363.31 Million ▲ +6.1 pp
2006 55.4% CN¥486.67 Million CN¥878.69 Million CN¥392.03 Million ▲ +0.4 pp
2005 55.0% CN¥479.80 Million CN¥872.24 Million CN¥392.44 Million ▼ -1.6 pp
2004 56.6% CN¥469.45 Million CN¥828.81 Million CN¥359.36 Million ▼ -4.3 pp
2003 60.9% CN¥451.69 Million CN¥741.34 Million CN¥289.65 Million ▲ +1.2 pp
2002 59.7% CN¥416.74 Million CN¥697.75 Million CN¥281.00 Million ▼ -12.0 pp
2001 71.7% CN¥401.79 Million CN¥560.38 Million CN¥158.59 Million ▼ -7.6 pp
2000 79.3% CN¥408.46 Million CN¥514.79 Million CN¥106.33 Million ▲ +43.9 pp
1999 35.5% CN¥62.08 Million CN¥175.02 Million CN¥112.94 Million ▼ -4.2 pp
1998 39.7% CN¥49.85 Million CN¥125.63 Million CN¥75.78 Million ▲ +1.8 pp
1997 37.9% CN¥33.98 Million CN¥89.69 Million CN¥55.71 Million
pp = percentage points